Pharmafile Logo

Glaucoma in perspective

Merck KGaA’s Oschmann elected president of IFPMA

He takes over from Lilly’s John Lechleiter

Roche - Basel

Roche invests in diagnostics in China

Commits 450m Swiss francs to manufacturing facility

- PMLiVE

Lundbeck still feeling effects from Cipralex patent loss

The antidepressant sales dropped another 33% in the third quarter

- PMLiVE

Former Vodafone UK comms head joins ABPI

Aileen Thompson appointed director of communications at UK pharma trade body

- PMLiVE

LabCorp to acquire Covance for $5.6bn

Combines diagnostics expertise with contract research

- PMLiVE

Successful partnerships in pharma: Skyepharma and Mundipharma

Why skills and flexibility matter more than sheer size

- PMLiVE

Actavis ‘considering’ white knight bid for Allergan

Wall Street Journal says Irish pharma company set to challenge Valeant's bid

- PMLiVE

Holistic market access and the importance of early engagement

There are two key elements in any successful strategy: knowing what to do, and knowing when to do it. Yet in terms of market access, there appears to be a...

- PMLiVE

AZ advances immuno-oncology ambitions

Buys imaging company and signs PD-1 collaborations with Pharmacyclics and J&J

Bristol-Myers Squibb (BMS) building

BMS takes option to buy fibrosis firm Galecto

The Swedish biotech has a pulmonary fibrosis candidate in early-stage testing

- PMLiVE

Astellas earmarks up to $1.2bn for protein folding research

Teams up with US company to investigate diseases caused by protein defects

- PMLiVE

Former NICE chair Sir Michael Rawlins to lead MHRA

He will take up his new role at the UK's medicines and devices regulator in December

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links